What drug is Apellis?

Alpelisib, whose English name isAlpelisib, is a targeted therapy drug for breast cancer patients with specific gene mutation types. This drug, developed by the Swiss company Novartis, has brought new treatment hope to many breast cancer patients carrying PIK3CA gene mutations.

The mechanism of action of Apelvis is to prevent the growth and spread of cancer cells by inhibiting the activity of thePI3K signaling pathway. The PI3K signaling pathway is often abnormally activated in various cancers, especially breast cancer, leading to the proliferation and survival of cancer cells. Apelvis can precisely act on this pathway to exert anti-tumor effects.

In clinical trials, apelvis combined with the endocrine therapy drug fulvestrant significantly prolonged the progression-free survival of patients with HR+/HER2- advanced or metastatic breast cancer carryingPIK3CA mutations. This means that for patients with this specific genotype, Apelvis can effectively control the progression of the disease and improve the patient's quality of life.

In addition to its remarkable efficacy, Apelvis is also relatively convenient to take. It is an oral tablet that patients can use conveniently at home. However, like other anti-cancer drugs, Apelvis may also cause some side effects, such as increased blood sugar, diarrhea, rash, etc. Therefore, during use, patients need to closely monitor their physical condition and maintain communication with their doctors so that the treatment plan can be adjusted in a timely manner.

It is worth noting that Apelvis is not yet widely available in mainland China, but it has been approved for clinical treatment in some countries and regions. For domestic patients, if they meet the conditions for medication and want to try this new treatment method, they can obtain the medication through legal channels and undergo treatment under the guidance of professional doctors.

Overall, apelvis, as a new type of targeted therapy, provides a new treatment option for patients with specific genotypes of breast cancer. Its emergence not only reflects the progress of modern medicine in precision treatment, but also brings more hope for survival to patients.